Strategic Financial Concepts LLC Makes New Investment in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Strategic Financial Concepts LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 19,968 shares of the company’s stock, valued at approximately $1,312,000. Strategic Financial Concepts LLC owned about 0.20% of iShares U.S. Pharmaceuticals ETF at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Stratos Wealth Advisors LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 3rd quarter worth about $250,000. Sequoia Financial Advisors LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF in the third quarter valued at approximately $204,000. Allworth Financial LP raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 9.4% during the third quarter. Allworth Financial LP now owns 1,853 shares of the company’s stock valued at $131,000 after buying an additional 159 shares during the last quarter. Southern Capital Advisors LLC boosted its position in shares of iShares U.S. Pharmaceuticals ETF by 1.1% during the third quarter. Southern Capital Advisors LLC now owns 40,280 shares of the company’s stock worth $2,844,000 after buying an additional 448 shares during the period. Finally, US Bancorp DE grew its holdings in iShares U.S. Pharmaceuticals ETF by 137.0% in the 3rd quarter. US Bancorp DE now owns 384 shares of the company’s stock worth $27,000 after buying an additional 222 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of iShares U.S. Pharmaceuticals ETF stock opened at $70.09 on Wednesday. iShares U.S. Pharmaceuticals ETF has a 1-year low of $62.67 and a 1-year high of $72.94. The business’s fifty day moving average price is $67.52 and its two-hundred day moving average price is $69.18. The company has a market capitalization of $707.91 million, a P/E ratio of 6.49 and a beta of 0.58.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.